Health News
Spotting the Treatment Gap in Diabetes Screening
Patients with severe mental illness face an increased risk for diabetes. And new evidence suggests there may be room for improvement when it comes to screening these patients for the condition.
Mental Health Rx Gets Go-Ahead
A newly approved medication could help some patients with serious mental health disorders.
Schizophrenia, Bipolar Disorder Rx Approved
DUBLIN and BUDAPEST, Hungary, Sept. 17, 2015 /PRNewswire/ -- Allergan plc (NYSE: AGN) and Gedeon Richter Plc. announced today that the U.S. Food and Drug Administration (FDA) has approved VRAYLAR™ (cariprazine) capsules, an atypical antipsychotic, for the acute treatment of manic or mixed episodes associated with bipolar I disorder and for treatment of schizophrenia in adults.
Among Teens, Antipsychotics May Be Too Common
Mental illness consists of an array of complex and hard-to-pin-down disorders, but avoiding misdiagnosis can be crucial to treating it properly.
Bipolar Disorder: What You Need to Know
More than 5 million Americans are affected by bipolar disorder, according to the National Institute of Mental Health (NIMH). An estimated 51 percent of adult patients with bipolar disorder go without treatment in a given year. Read on to learn the differences between bipolar disorder and mood swings, and what to do if a family member or friend needs support.
Under Debate: Psychiatric Medications
Medications are often prescribed to treat mental conditions, but are they all they’re cracked up to be? Some have raised concerns that psychiatric medications may have overstated benefits and underreported harms.
First-Ever Generic Abilify Gets FDA Go-Ahead
Four pharmaceutical companies received approval today from the US Food and Drug Administration (FDA) to market generic versions of Abilify, an atypical antipsychotic drug.
First Generic Abilify Approved
The U.S. Food and Drug Administration today approved the first generic versions of Abilify (aripiprazole).
Get Help for Depression in Pregnancy
Depression can take all the fun out of being a new mother. Researchers are trying to find better ways to diagnose the problem early.
FDA Warns of Rare but Serious Skin Reactions from Ziprasidone
FDA is warning that the antipsychotic drug ziprasidone (marketed under the brand name, Geodon, and its generics) is associated with a rare but serious skin reaction that can progress to affect other parts of the body.